Literature DB >> 33659382

Co-culture of Murine Neurons Using a Microfluidic Device for The Study of Tau Misfolding Propagation.

Grace I Hallinan1, Dianne M Lopez1, Mariana Vargas-Caballero1, Jonathan West2, Katrin Deinhardt1.   

Abstract

The deposition of misfolded, aggregated tau protein is a hallmark of several neurodegenerative diseases, collectively termed "tauopathies". Tau pathology spreads throughout the brain along connected pathways in a prion-like manner. The process of tau pathology propagation across circuits is a focus of intense research and has been investigated in vivo in human post-mortem brain and in mouse models of the diseases, in vitro in diverse cellular systems including primary neurons, and in cell free assays using purified recombinant tau protein. Here we describe a protocol that takes advantage of a minimalistic neuronal circuit arrayed within a microfluidic device to follow the propagation of tau misfolding from a presynaptic to a postsynaptic neuron. This assay allows high-resolution imaging as well as individual manipulation of the releasing and receiving neuron, and is therefore beneficial for investigating the propagation of tau and other misfolded proteins in vitro.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Hippocampal culture; Image analysis; Imaging; Microfluidic device; Protein misfolding propagation; Tau

Year:  2020        PMID: 33659382      PMCID: PMC7842501          DOI: 10.21769/BioProtoc.3718

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  16 in total

Review 1.  The propagation of prion-like protein inclusions in neurodegenerative diseases.

Authors:  Michel Goedert; Florence Clavaguera; Markus Tolnay
Journal:  Trends Neurosci       Date:  2010-05-20       Impact factor: 13.837

2.  A microfluidic culture platform for CNS axonal injury, regeneration and transport.

Authors:  Anne M Taylor; Mathew Blurton-Jones; Seog Woo Rhee; David H Cribbs; Carl W Cotman; Noo Li Jeon
Journal:  Nat Methods       Date:  2005-08       Impact factor: 28.547

3.  Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).

Authors:  Martin Ramsden; Linda Kotilinek; Colleen Forster; Jennifer Paulson; Eileen McGowan; Karen SantaCruz; Aaron Guimaraes; Mei Yue; Jada Lewis; George Carlson; Michael Hutton; Karen H Ashe
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

4.  Asymmetric confinement for defining outgrowth directionality.

Authors:  Paul M Holloway; Grace I Hallinan; Manjunath Hegde; Simon I R Lane; Katrin Deinhardt; Jonathan West
Journal:  Lab Chip       Date:  2019-04-09       Impact factor: 6.799

5.  Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

Authors:  Bridget Allen; Esther Ingram; Masaki Takao; Michael J Smith; Ross Jakes; Kanwar Virdee; Hirotaka Yoshida; Max Holzer; Molly Craxton; Piers C Emson; Cristiana Atzori; Antonio Migheli; R Anthony Crowther; Bernardino Ghetti; Maria Grazia Spillantini; Michel Goedert
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

6.  Trans-cellular propagation of Tau aggregation by fibrillar species.

Authors:  Najla Kfoury; Brandon B Holmes; Hong Jiang; David M Holtzman; Marc I Diamond
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

7.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

Review 8.  Minimalistic in vitro systems for investigating tau pathology.

Authors:  Grace I Hallinan; Aleksandra P Pitera; Prutha Patel; Jonathan West; Katrin Deinhardt
Journal:  J Neurosci Methods       Date:  2018-09-29       Impact factor: 2.390

9.  GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.

Authors:  Garrett S Gibbons; Rachel A Banks; Bumjin Kim; Hong Xu; Lakshmi Changolkar; Susan N Leight; Dawn M Riddle; Chi Li; Ronald J Gathagan; Hannah J Brown; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2017-10-06       Impact factor: 6.167

10.  Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.

Authors:  Shuko Takeda; Susanne Wegmann; Hansang Cho; Sarah L DeVos; Caitlin Commins; Allyson D Roe; Samantha B Nicholls; George A Carlson; Rose Pitstick; Chloe K Nobuhara; Isabel Costantino; Matthew P Frosch; Daniel J Müller; Daniel Irimia; Bradley T Hyman
Journal:  Nat Commun       Date:  2015-10-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.